Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
57 studies found for:    "Long QT syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Long QT syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed The Long QT Syndrome in Pregnancy
Condition: Long QT Syndrome
Intervention:
2 Recruiting Long QT Syndrome Screening in Newborns
Condition: Long QT Syndrome
Intervention: Device: QTScreen ECG Recorder
3 Recruiting The Canadian National Long QT Syndrome Registry
Condition: Long QT Syndrome
Intervention:
4 Recruiting Prospective Identification of Long QT Syndrome in Fetal Life
Condition: Long QT Syndrome
Intervention:
5 Recruiting Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Condition: Long QT Syndrome
Intervention:
6 Not yet recruiting Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome
Condition: Long QT Syndrome
Interventions: Drug: Moxifloxacin;   Dietary Supplement: Grapefruit group
7 Active, not recruiting Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
Condition: Long QT Syndrome Type 3
Interventions: Drug: Eleclazine;   Drug: Eleclazine placebo
8 Recruiting Abnormal QT-Response to the Sudden Tachycardia Provoked by Standing in Individuals With Drug-induced Long QT Syndrome
Condition: Long QT Syndrome
Intervention: Device: tilt table
9 Completed Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
Condition: Long QT Syndrome
Interventions: Drug: GS-6615;   Drug: Placebo to match GS-6615;   Drug: Placebo to match dofetilide;   Drug: Dofetilide
10 Recruiting Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
Condition: Long QT Syndrome Type 3
Intervention: Drug: Ranolazine
11 Completed Study of the Effect of GS-6615 in Subjects With LQT-3
Condition: Long QT Syndrome
Intervention: Drug: GS-6615
12 Recruiting Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients
Condition: Long QT Syndrome Type 1 or 2
Interventions: Other: exercise test;   Other: Epinephrine test
13 Completed Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function
Condition: Long QT Syndrome
Intervention: Drug: Eleclazine
14 Recruiting Efficacy Study of Sodium Channel Blocker in LQT3 Patients
Condition: Long QT Syndrome
Interventions: Drug: Placebo;   Drug: Ranolazine
15 Recruiting Long QT and Hearing Loss Registry
Conditions: Sensorineural Hearing Loss;   Long QT Syndrome
Intervention:
16 Recruiting Genetics of QT Prolongation With Antiarrhythmics
Conditions: Long QT Syndrome;   Drug Toxicity
Intervention: Drug: Dofetilide and/or sotalol
17 Active, not recruiting Metabolism of Patients With Genetically Caused Cardiac Arrhythmia
Condition: Long QT Syndrome
Intervention:
18 Completed Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
Condition: Long QT Syndrome
Intervention: Drug: Eleclazine
19 Completed QT-prolongation in Psychiatric Hospitals
Condition: QT-prolongation
Intervention: Drug: drugs linked with QT-prolongation
20 Completed Drug Interactions With Risk of QT-prolongation in a General Hospital
Condition: QT-prolongation
Intervention: Drug: Haloperidol

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.